Ticker Symbol: GOSS
Gossamer Bio Inc
$11.79 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001728117
Company Profile
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 3013 Science Park Rd
Website: www.gossamerbio.com
CEO: Sheila Gujrathi
Tags:
- Pharmaceuticals: Major
- Health Technology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.72
Change:
-$0.04
(
-5.57%)
Days Range: $0.70 - $0.76
Beta: 2.32
52wk. High: $12.79
52wk. Low: $0.54
Ytd. Change -70.16%
50 Day Moving Average: $0.80
200 Day Moving Average: $1.13
Shares Outstanding: 225322142
Valuation
Market Cap: 16.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A